Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이용호 | - |
dc.contributor.author | 조용인 | - |
dc.contributor.author | 이병완 | - |
dc.contributor.author | 박철영 | - |
dc.contributor.author | 이대호 | - |
dc.contributor.author | 차봉수 | - |
dc.contributor.author | 이은정 | - |
dc.date.available | 2020-02-27T07:40:51Z | - |
dc.date.created | 2020-02-12 | - |
dc.date.issued | 2019-02 | - |
dc.identifier.issn | 2233-6079 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/2647 | - |
dc.description.abstract | Nonalcoholic fatty liver disease (NAFLD) and diabetes are common metabolic disorders whose prevalence rates are expected to rise worldwide, corresponding to aging and increasingly obese populations. Compared to the general population (around 25%), 50% to 70% of people with diabetes have NAFLD, and NAFLD severity (including fibrosis) tends to be worsened by the presence of diabetes. NAFLD is considered an emerging risk factor for type 2 diabetes mellitus and a contributor to the development of chronic diabetes-related complications. This reciprocal relationship demonstrates the importance of confirming suspected NAFLD in patients with diabetes. Due to the invasive nature of liver biopsy to assess NAFLD status, various alternative non-invasive modalities have been developed and validated. Here, we summarized the epidemiology of NAFLD in patients with diabetes and reviewed currently available imaging modalities and biomarker-based prediction models for their ability to detect liver steatosis and/or fibrosis. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | 대한당뇨병학회 | - |
dc.relation.isPartOf | Diabetes and Metabolism Journal | - |
dc.title | Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000459349300003 | - |
dc.identifier.doi | 10.4093/dmj.2019.0011 | - |
dc.identifier.bibliographicCitation | Diabetes and Metabolism Journal, v.43, no.1, pp.31 - 45 | - |
dc.identifier.kciid | ART002437408 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85063409633 | - |
dc.citation.endPage | 45 | - |
dc.citation.startPage | 31 | - |
dc.citation.title | Diabetes and Metabolism Journal | - |
dc.citation.volume | 43 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | 이대호 | - |
dc.subject.keywordAuthor | Diabetes mellitus | - |
dc.subject.keywordAuthor | Diagnosis | - |
dc.subject.keywordAuthor | Epidemiology | - |
dc.subject.keywordAuthor | Non-alcoholic fatty liver disease | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.